-
1
-
-
0036237268
-
Therapy of secondary leukemia
-
Rowe JM. Therapy of secondary leukemia. Leukemia. 2002;16(4):748-50.
-
(2002)
Leukemia.
, vol.16
, Issue.4
, pp. 748-750
-
-
Rowe, J.M.1
-
2
-
-
70349256226
-
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes
-
Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114(5): 937-51.
-
(2009)
Blood.
, vol.114
, Issue.5
, pp. 937-951
-
-
Vardiman, J.W.1
Thiele, J.2
Arber, D.A.3
Brunning, R.D.4
Borowitz, M.J.5
Porwit, A.6
-
3
-
-
48749090278
-
Therapy-related myeloid leukemia
-
Godley LA, Larson RA. Therapy-related myeloid leukemia. Semin Oncol. 2008;35 (4):418-29.
-
(2008)
Semin Oncol.
, vol.35
, Issue.4
, pp. 418-429
-
-
Godley, L.A.1
Larson, R.A.2
-
4
-
-
79951825094
-
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML
-
Kayser S, Dohner K, Krauter J, Kohne CH, Horst HA, Held G, et al. The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. Blood. 117(7):2137-45.
-
Blood.
, vol.117
, Issue.7
, pp. 2137-2145
-
-
Kayser, S.1
Dohner, K.2
Krauter, J.3
Kohne, C.H.4
Horst, H.A.5
Held, G.6
-
5
-
-
33748750051
-
Cancer immunosuppression and autoimmune disease: Beyond immunosuppressive networks for tumour immunity
-
Kim R, Emi M, Tanabe K. Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity. Immunology. 2006;119 (2):254-64.
-
(2006)
Immunology.
, vol.119
, Issue.2
, pp. 254-264
-
-
Kim, R.1
Emi, M.2
Tanabe, K.3
-
6
-
-
3242756741
-
Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation
-
Offman J, Opelz G, Doehler B, Cummins D, Halil O, Banner NR, et al. Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation. Blood. 2004;104 (3):822-8.
-
(2004)
Blood.
, vol.104
, Issue.3
, pp. 822-828
-
-
Offman, J.1
Opelz, G.2
Doehler, B.3
Cummins, D.4
Halil, O.5
Banner, N.R.6
-
7
-
-
77956249684
-
Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic Acid and anthracycline-based chemotherapy
-
Montesinos P, Gonzalez JD, Gonzalez J, Rayon C, de Lisa E, Amigo ML, et al. Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic Acid and anthracycline-based chemotherapy. J Clin Oncol. 2010;28(24):3872-9.
-
(2010)
J Clin Oncol.
, vol.28
, Issue.24
, pp. 3872-3879
-
-
Montesinos, P.1
Gonzalez, J.D.2
Gonzalez, J.3
Rayon, C.4
de Lisa, E.5
Amigo, M.L.6
-
8
-
-
0141819043
-
The epidemiology of autoimmune diseases
-
Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev. 2003;2(3):119-25.
-
(2003)
Autoimmun Rev.
, vol.2
, Issue.3
, pp. 119-125
-
-
Cooper, G.S.1
Stroehla, B.C.2
-
9
-
-
71649086164
-
Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases
-
Cooper GS, Bynum ML, Somers EC. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun. 2009;33(3-4):197-207.
-
(2009)
J Autoimmun.
, vol.33
, Issue.3-4
, pp. 197-207
-
-
Cooper, G.S.1
Bynum, M.L.2
Somers, E.C.3
-
10
-
-
0037006252
-
Relative importance of genetic effects in rheumatoid arthritis: Historical cohort study of Danish nationwide twin population
-
Svendsen AJ, Holm NV, Kyvik K, Petersen PH, Junker P. Relative importance of genetic effects in rheumatoid arthritis: historical cohort study of Danish nationwide twin population. BMJ. 2002;324(7332):264-6.
-
(2002)
BMJ.
, vol.324
, Issue.7332
, pp. 264-266
-
-
Svendsen, A.J.1
Holm, N.V.2
Kyvik, K.3
Petersen, P.H.4
Junker, P.5
-
11
-
-
79551512143
-
Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the Women's Health Initiative Observational Study
-
Parks CG, Walitt BT, Pettinger M, Chen JC, de Roos AJ, Hunt J, et al. Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the Women's Health Initiative Observational Study. Arthritis Care Res (Hoboken). 2011;63(2):184-94.
-
(2011)
Arthritis Care Res (Hoboken).
, vol.63
, Issue.2
, pp. 184-194
-
-
Parks, C.G.1
Walitt, B.T.2
Pettinger, M.3
Chen, J.C.4
de Roos, A.J.5
Hunt, J.6
-
12
-
-
33750301846
-
Occupational and environmental associations with antinuclear antibodies in a general population sample
-
Cooper GS, Parks CG, Schur PS, Fraser PA. Occupational and environmental associations with antinuclear antibodies in a general population sample. J Toxicol Environ Health A. 2006;69(23):2063-9.
-
(2006)
J Toxicol Environ Health A.
, vol.69
, Issue.23
, pp. 2063-2069
-
-
Cooper, G.S.1
Parks, C.G.2
Schur, P.S.3
Fraser, P.A.4
-
13
-
-
16544385459
-
Occupational and environmental exposures as risk factors for systemic lupus erythematosus
-
Cooper GS, Parks CG. Occupational and environmental exposures as risk factors for systemic lupus erythematosus. Curr Rheumatol Rep. 2004;6(5):367-74.
-
(2004)
Curr Rheumatol Rep.
, vol.6
, Issue.5
, pp. 367-374
-
-
Cooper, G.S.1
Parks, C.G.2
-
15
-
-
42649143294
-
Skewing of X chromosome inactivation in autoimmunity
-
Invernizzi P, Pasini S, Selmi C, Miozzo M, Podda M. Skewing of X chromosome inactivation in autoimmunity. Autoimmunity. 2008;41(4):272-7.
-
(2008)
Autoimmunity.
, vol.41
, Issue.4
, pp. 272-277
-
-
Invernizzi, P.1
Pasini, S.2
Selmi, C.3
Miozzo, M.4
Podda, M.5
-
16
-
-
0142061467
-
Epidemiology of multiple sclerosis: Environmental factors versus genetic factors
-
Kira J. [Epidemiology of multiple sclerosis: environmental factors versus genetic factors]. Nippon Rinsho. 2003;61(8):1300-10.
-
(2003)
Nippon Rinsho.
, vol.61
, Issue.8
, pp. 1300-1310
-
-
Kira, J.1
-
18
-
-
38449084395
-
Genetic analysis of systemic autoimmunity
-
discussion 120-8, 208-9
-
Vinuesa CG, Cook MC. Genetic analysis of systemic autoimmunity. Novartis Found Symp. 2007;281:103-20; discussion 120-8, 208-9.
-
(2007)
Novartis Found Symp.
, vol.281
, pp. 103-120
-
-
Vinuesa, C.G.1
Cook, M.C.2
-
19
-
-
77950355043
-
Unraveling the genetics of autoimmunity
-
Zenewicz LA, Abraham C, Flavell RA, Cho JH. Unraveling the genetics of autoimmunity. Cell. 2010;140(6):791-7.
-
(2010)
Cell.
, vol.140
, Issue.6
, pp. 791-797
-
-
Zenewicz, L.A.1
Abraham, C.2
Flavell, R.A.3
Cho, J.H.4
-
20
-
-
45349090538
-
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
-
Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008;59(6):762-84.
-
(2008)
Arthritis Rheum.
, vol.59
, Issue.6
, pp. 762-784
-
-
Saag, K.G.1
Teng, G.G.2
Patkar, N.M.3
Anuntiyo, J.4
Finney, C.5
Curtis, J.R.6
-
21
-
-
61749100610
-
Risks of myeloid malignancies in patients with autoimmune conditions
-
Anderson LA, Pfeiffer RM, Landgren O, Gadalla S, Berndt SI, Engels EA. Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer. 2009; 100(5):822-8.
-
(2009)
Br J Cancer.
, vol.100
, Issue.5
, pp. 822-828
-
-
Anderson, L.A.1
Pfeiffer, R.M.2
Landgren, O.3
Gadalla, S.4
Berndt, S.I.5
Engels, E.A.6
-
22
-
-
79960709287
-
Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes
-
Kristinsson SY, Bjorkholm M, Hultcrantz M, Derolf AR, Landgren O, Goldin LR. Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol. 29(21):2897-903.
-
J Clin Oncol.
, vol.29
, Issue.21
, pp. 2897-2903
-
-
Kristinsson, S.Y.1
Bjorkholm, M.2
Hultcrantz, M.3
Derolf, A.R.4
Landgren, O.5
Goldin, L.R.6
-
23
-
-
0017644690
-
Acute leukemia after azathioprine treatment of connective tissue disease
-
Alexson E, Brandt KD. Acute leukemia after azathioprine treatment of connective tissue disease. Am J Med Sci. 1977;273 (3):335-40.
-
(1977)
Am J Med Sci.
, vol.273
, Issue.3
, pp. 335-340
-
-
Alexson, E.1
Brandt, K.D.2
-
24
-
-
0032527868
-
Acute myeloid leukemia after azathioprine treatment for autoimmune diseases: Association with-7/7q
-
Kwong YL, Au WY, Liang RH. Acute myeloid leukemia after azathioprine treatment for autoimmune diseases: association with-7/7q. Cancer Genet Cytogenet. 1998;104(2):94-7.
-
(1998)
Cancer Genet Cytogenet.
, vol.104
, Issue.2
, pp. 94-97
-
-
Kwong, Y.L.1
Au, W.Y.2
Liang, R.H.3
-
25
-
-
0036693720
-
Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: A coincidental coexistence or a causal relationship
-
Espinosa G, Font J, Munoz-Rodriguez FJ, Cervera R, Ingelmo M. Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship? Clin Rheumatol. 2002;21(4):309-13.
-
(2002)
Clin Rheumatol.
, vol.21
, Issue.4
, pp. 309-313
-
-
Espinosa, G.1
Font, J.2
Munoz-Rodriguez, F.J.3
Cervera, R.4
Ingelmo, M.5
-
26
-
-
0345731425
-
Myelodysplastic syndrome associated with low-dose methotrexate in rheumatoid arthritis
-
Okamoto H, Teramura M, Kamatani N. Myelodysplastic syndrome associated with low-dose methotrexate in rheumatoid arthritis. Ann Pharmacother. 2004;38(1): 172-3.
-
(2004)
Ann Pharmacother.
, vol.38
, Issue.1
, pp. 172-173
-
-
Okamoto, H.1
Teramura, M.2
Kamatani, N.3
-
27
-
-
20044387442
-
Acute erythroleukemia in a rheumatoid arthritis patient during low-dose methotrexate therapy
-
Choi BR, Ahn MJ, Lee WS, Kim TH, Bae SC, Jun JB. Acute erythroleukemia in a rheumatoid arthritis patient during low-dose methotrexate therapy. Rheumatol Int. 2005;25(4):311-3.
-
(2005)
Rheumatol Int.
, vol.25
, Issue.4
, pp. 311-313
-
-
Choi, B.R.1
Ahn, M.J.2
Lee, W.S.3
Kim, T.H.4
Bae, S.C.5
Jun, J.B.6
-
28
-
-
13944276418
-
Myelodysplasia and acute myeloid leukaemia in a case of rheumatoid arthritis with secondary amyloidosis treated with chlorambucil
-
Balakrishnan C, Pathan E, Khodaiji S, Dasgupta A, Mangat G, Joshi VR. Myelodysplasia and acute myeloid leukaemia in a case of rheumatoid arthritis with secondary amyloidosis treated with chlorambucil. J Assoc Physicians India. 2004;52:423-5.
-
(2004)
J Assoc Physicians India.
, vol.52
, pp. 423-425
-
-
Balakrishnan, C.1
Pathan, E.2
Khodaiji, S.3
Dasgupta, A.4
Mangat, G.5
Joshi, V.R.6
-
29
-
-
58149332852
-
Adalimumab-induced acute myelogenic leukemia
-
Saba NS, Kosseifi SG, Charaf EA, Hammad AN. Adalimumab-induced acute myelogenic leukemia. South Med J. 2008;101 (12):1261-2.
-
(2008)
South Med J.
, vol.101
, Issue.12
, pp. 1261-1262
-
-
Saba, N.S.1
Kosseifi, S.G.2
Charaf, E.A.3
Hammad, A.N.4
-
30
-
-
0029828620
-
Myelodysplastic syndromes and acute myeloid leukemia in connective tissue disease after single-agent chemotherapy
-
Rosenthal NS, Farhi DC. Myelodysplastic syndromes and acute myeloid leukemia in connective tissue disease after single-agent chemotherapy. Am J Clin Pathol. 1996;106 (5):676-9.
-
(1996)
Am J Clin Pathol.
, vol.106
, Issue.5
, pp. 676-679
-
-
Rosenthal, N.S.1
Farhi, D.C.2
-
31
-
-
0018110856
-
Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis
-
Isomaki HA, Hakulinen T, Joutsenlahti U. Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis. 1978;31(11):691-6.
-
(1978)
J Chronic Dis.
, vol.31
, Issue.11
, pp. 691-696
-
-
Isomaki, H.A.1
Hakulinen, T.2
Joutsenlahti, U.3
-
32
-
-
0027528555
-
Incidence of cancer among patients with rheumatoid arthritis
-
Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst. 1993;85(4):307-11.
-
(1993)
J Natl Cancer Inst.
, vol.85
, Issue.4
, pp. 307-311
-
-
Gridley, G.1
McLaughlin, J.K.2
Ekbom, A.3
Klareskog, L.4
Adami, H.O.5
Hacker, D.G.6
-
33
-
-
0006050423
-
Rheumatoid arthritis and cancer risk
-
Mellemkjaer L, Linet MS, Gridley G, Frisch M, Moller H, Olsen JH. Rheumatoid arthritis and cancer risk. Eur J Cancer. 1996; 32A(10):1753-7.
-
(1996)
Eur J Cancer.
, vol.32 A
, Issue.10
, pp. 1753-1757
-
-
Mellemkjaer, L.1
Linet, M.S.2
Gridley, G.3
Frisch, M.4
Moller, H.5
Olsen, J.H.6
-
34
-
-
0021924601
-
Cancer and rheumatoid arthritis: Epidemiologic considerations
-
Prior P. Cancer and rheumatoid arthritis: epidemiologic considerations. Am J Med. 1985;78(1A):15-21.
-
(1985)
Am J Med.
, vol.78
, Issue.1 A
, pp. 15-21
-
-
Prior, P.1
-
35
-
-
0030848726
-
Rheumatoid arthritis and the risk of malignancy
-
Cibere J, Sibley J, Haga M. Rheumatoid arthritis and the risk of malignancy. Arthritis Rheum. 1997;40(9):1580-6.
-
(1997)
Arthritis Rheum.
, vol.40
, Issue.9
, pp. 1580-1586
-
-
Cibere, J.1
Sibley, J.2
Haga, M.3
-
36
-
-
27744520447
-
Haematopoietic malignancies in rheumatoid arthritis: Lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
-
Askling J, Fored CM, Baecklund E, Brandt L, Backlin C, Ekbom A, et al. Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis. 2005;64(10):1414-20.
-
(2005)
Ann Rheum Dis.
, vol.64
, Issue.10
, pp. 1414-1420
-
-
Askling, J.1
Fored, C.M.2
Baecklund, E.3
Brandt, L.4
Backlin, C.5
Ekbom, A.6
-
37
-
-
68849126243
-
Risk of cancer among rheumatoid arthritis patients in California
-
Parikh-Patel A, White RH, Allen M, Cress R. Risk of cancer among rheumatoid arthritis patients in California. Cancer Causes Control. 2009;20(6):1001-10.
-
(2009)
Cancer Causes Control.
, vol.20
, Issue.6
, pp. 1001-1010
-
-
Parikh-Patel, A.1
White, R.H.2
Allen, M.3
Cress, R.4
-
38
-
-
42949097388
-
Cancer risk in hospitalized rheumatoid arthritis patients
-
Hemminki K, Li X, Sundquist K, Sundquist J. Cancer risk in hospitalized rheumatoid arthritis patients. Rheumatology (Oxford). 2008;47(5):698-701.
-
(2008)
Rheumatology (Oxford).
, vol.47
, Issue.5
, pp. 698-701
-
-
Hemminki, K.1
Li, X.2
Sundquist, K.3
Sundquist, J.4
-
39
-
-
40449106365
-
Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis
-
Bernatsky S, Clarke AE, Suissa S. Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis. Arch Intern Med. 2008;168(4):378-81.
-
(2008)
Arch Intern Med.
, vol.168
, Issue.4
, pp. 378-381
-
-
Bernatsky, S.1
Clarke, A.E.2
Suissa, S.3
-
40
-
-
66149084485
-
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: Relative risks and time trends in the Swedish Biologics Register
-
Askling J, Baecklund E, Granath F, Geborek P, Fored M, Backlin C, et al. Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register. Ann Rheum Dis. 2009;68(5):648-53.
-
(2009)
Ann Rheum Dis.
, vol.68
, Issue.5
, pp. 648-653
-
-
Askling, J.1
Baecklund, E.2
Granath, F.3
Geborek, P.4
Fored, M.5
Backlin, C.6
-
41
-
-
17644374819
-
Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
-
Geborek P, Bladstrom A, Turesson C, Gulfe A, Petersson IF, Saxne T, et al. Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas. Ann Rheum Dis. 2005;64(5):699-703.
-
(2005)
Ann Rheum Dis.
, vol.64
, Issue.5
, pp. 699-703
-
-
Geborek, P.1
Bladstrom, A.2
Turesson, C.3
Gulfe, A.4
Petersson, I.F.5
Saxne, T.6
-
42
-
-
33749346419
-
Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis
-
Setoguchi S, Solomon DH, Weinblatt ME, Katz JN, Avorn J, Glynn RJ, et al. Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum. 2006;54(9):2757-64.
-
(2006)
Arthritis Rheum.
, vol.54
, Issue.9
, pp. 2757-2764
-
-
Setoguchi, S.1
Solomon, D.H.2
Weinblatt, M.E.3
Katz, J.N.4
Avorn, J.5
Glynn, R.J.6
-
43
-
-
0032931201
-
Efficacy and safety of a combination therapy of methotrexate, chloroquine and cyclophosphamide in patients with refractory rheumatoid arthritis: Results of an observational study with matched-pair analysis
-
Keyszer G, Keysser C, Keysser M. Efficacy and safety of a combination therapy of methotrexate, chloroquine and cyclophosphamide in patients with refractory rheumatoid arthritis: results of an observational study with matched-pair analysis. Clin Rheumatol. 1999;18(2):145-51.
-
(1999)
Clin Rheumatol.
, vol.18
, Issue.2
, pp. 145-151
-
-
Keyszer, G.1
Keysser, C.2
Keysser, M.3
-
44
-
-
0141564911
-
Rate of death due to leukemia/lymphoma in patients with rheumatoid arthritis
-
Wolfe F, Fries JF. Rate of death due to leukemia/lymphoma in patients with rheumatoid arthritis. Arthritis Rheum. 2003;48(9):2694-5.
-
(2003)
Arthritis Rheum.
, vol.48
, Issue.9
, pp. 2694-2695
-
-
Wolfe, F.1
Fries, J.F.2
-
45
-
-
44349093644
-
Cancer in rheumatoid arthritis: Occurrence, mortality, and associated factors in a South European population
-
Abasolo L, Judez E, Descalzo MA, Gonzalez-Alvaro I, Jover JA, Carmona L. Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a South European population. Semin Arthritis Rheum. 2008;37(6):388-97.
-
(2008)
Semin Arthritis Rheum.
, vol.37
, Issue.6
, pp. 388-397
-
-
Abasolo, L.1
Judez, E.2
Descalzo, M.A.3
Gonzalez-Alvaro, I.4
Jover, J.A.5
Carmona, L.6
-
46
-
-
0347991877
-
The safety profile of infliximab in patients with Crohn's disease: The Mayo clinic experience in 500 patients
-
Colombel JF, Loftus EV Jr, Tremaine WJ, Egan LJ, Harmsen WS, Schleck CD, et al. The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. Gastroenterology. 2004;126(1):19-31.
-
(2004)
Gastroenterology.
, vol.126
, Issue.1
, pp. 19-31
-
-
Colombel, J.F.1
Loftus Jr., E.V.2
Tremaine, W.J.3
Egan, L.J.4
Harmsen, W.S.5
Schleck, C.D.6
-
47
-
-
69749083197
-
Emerging issues in ulcerative colitis and ulcerative proctitis: Individualizing treatment to maximize outcomes
-
Hanauer SB, Present DH, Rubin DT. Emerging issues in ulcerative colitis and ulcerative proctitis: individualizing treatment to maximize outcomes. Gastroenterol Hepatol (NY). 2009;5(6 Suppl):4-16.
-
(2009)
Gastroenterol Hepatol (NY).
, vol.5
, Issue.6 SUPPL.
, pp. 4-16
-
-
Hanauer, S.B.1
Present, D.H.2
Rubin, D.T.3
-
48
-
-
2442563304
-
Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences
-
Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004;126(6):1504-17.
-
(2004)
Gastroenterology.
, vol.126
, Issue.6
, pp. 1504-1517
-
-
Loftus Jr., E.V.1
-
50
-
-
0019171681
-
Acute myelogenous leukemia in patients with ulcerative colitis
-
Fabry TL, Sachar DB, Janowitz HD. Acute myelogenous leukemia in patients with ulcerative colitis. J Clin Gastroenterol. 1980; 2(3):225-7.
-
(1980)
J Clin Gastroenterol.
, vol.2
, Issue.3
, pp. 225-227
-
-
Fabry, T.L.1
Sachar, D.B.2
Janowitz, H.D.3
-
51
-
-
0025911925
-
Acute promyelocytic leukemia in Crohn's disease. Case report and review of the literature
-
Orii S, Sugai T, Nakano O, Yoshinari H, Sato S. Acute promyelocytic leukemia in Crohn's disease. Case report and review of the literature. J Clin Gastroenterol. 1991;13(3):325-7.
-
(1991)
J Clin Gastroenterol.
, vol.13
, Issue.3
, pp. 325-327
-
-
Orii, S.1
Sugai, T.2
Nakano, O.3
Yoshinari, H.4
Sato, S.5
-
52
-
-
0029152855
-
De novo acute myeloid leukemia in patients with Crohn's disease
-
Dombret H, Marolleau JP. De novo acute myeloid leukemia in patients with Crohn's disease. Nouv Rev Fr Hematol. 1995;37 (3):193-6.
-
(1995)
Nouv Rev Fr Hematol.
, vol.37
, Issue.3
, pp. 193-196
-
-
Dombret, H.1
Marolleau, J.P.2
-
53
-
-
0020058511
-
Acute leukemia following inflammatory bowel disease
-
Hanauer SB, Wong KK, Frank PH, Sweet DL, Kirsner JB. Acute leukemia following inflammatory bowel disease. Dig Dis Sci. 1982;27(6):545-8.
-
(1982)
Dig Dis Sci.
, vol.27
, Issue.6
, pp. 545-548
-
-
Hanauer, S.B.1
Wong, K.K.2
Frank, P.H.3
Sweet, D.L.4
Kirsner, J.B.5
-
54
-
-
0021333214
-
Inflammatory bowel disease and leukemia
-
Cohn EM, Pearlstine B. Inflammatory bowel disease and leukemia. J Clin Gastroenterol. 1984;6(1):33-5.
-
(1984)
J Clin Gastroenterol.
, vol.6
, Issue.1
, pp. 33-35
-
-
Cohn, E.M.1
Pearlstine, B.2
-
55
-
-
0025598283
-
Development of acute myelocytic leukemia in patients with Crohn's disease
-
Halme L, von Knorring J, Elonen E. Development of acute myelocytic leukemia in patients with Crohn's disease. Dig Dis Sci. 1990;35(12):1553-6.
-
(1990)
Dig Dis Sci.
, vol.35
, Issue.12
, pp. 1553-1556
-
-
Halme, L.1
von Knorring, J.2
Elonen, E.3
-
56
-
-
0028948834
-
Crohn disease and the myelodysplastic syndrome
-
Boberg KM, Brinch L, Vatn M. Crohn disease and the myelodysplastic syndrome. Ann Intern Med. 1995;122(5):395.
-
(1995)
Ann Intern Med.
, vol.122
, Issue.5
, pp. 395
-
-
Boberg, K.M.1
Brinch, L.2
Vatn, M.3
-
57
-
-
33947698296
-
Hematological malignancies in chronic inflammatory bowel diseases: Report of five cases and review of the literature
-
Crispino P, Pica R, Angelucci E, Consolazio A, Rivera M, Cassieri C, et al. Hematological malignancies in chronic inflammatory bowel diseases: report of five cases and review of the literature. Int J Colorectal Dis. 2007;22(5):553-8.
-
(2007)
Int J Colorectal Dis.
, vol.22
, Issue.5
, pp. 553-558
-
-
Crispino, P.1
Pica, R.2
Angelucci, E.3
Consolazio, A.4
Rivera, M.5
Cassieri, C.6
-
58
-
-
77956269303
-
Treatmentassociated acute myeloid leukemia in a patient with Crohn's disease on 6-mercaptopurine
-
Das KK, Nishino HT, Chan AT. Treatmentassociated acute myeloid leukemia in a patient with Crohn's disease on 6-mercaptopurine. Inflamm Bowel Dis. 2010;16(9): 1454-6.
-
(2010)
Inflamm Bowel Dis.
, vol.16
, Issue.9
, pp. 1454-1456
-
-
Das, K.K.1
Nishino, H.T.2
Chan, A.T.3
-
59
-
-
77957568167
-
Acute myeloid leukemia after one month of azathioprine therapy in a Crohn's disease patient
-
Kallel L, Naijaa N, Fekih M, Frikha I, Boubaker J, Bellaaj H, et al. Acute myeloid leukemia after one month of azathioprine therapy in a Crohn's disease patient. J Clin Gastroenterol. 2010;44(9):660.
-
(2010)
J Clin Gastroenterol.
, vol.44
, Issue.9
, pp. 660
-
-
Kallel, L.1
Naijaa, N.2
Fekih, M.3
Frikha, I.4
Boubaker, J.5
Bellaaj, H.6
-
60
-
-
0022410723
-
Extraintestinal cancers in inflammatory bowel disease
-
Greenstein AJ, Gennuso R, Sachar DB, Heimann T, Smith H, Janowitz HD, et al. Extraintestinal cancers in inflammatory bowel disease. Cancer. 1985;56(12):2914-21.
-
(1985)
Cancer.
, vol.56
, Issue.12
, pp. 2914-2921
-
-
Greenstein, A.J.1
Gennuso, R.2
Sachar, D.B.3
Heimann, T.4
Smith, H.5
Janowitz, H.D.6
-
61
-
-
0022543170
-
Inflammatory bowel disease and leukemia. A report of seven cases of leukemia in ulcerative colitis and Crohn's disease and review of the literature
-
Mir Madjlessi SH, Farmer RG, Weick JK. Inflammatory bowel disease and leukemia. A report of seven cases of leukemia in ulcerative colitis and Crohn's disease and review of the literature. Dig Dis Sci. 1986;31(10): 1025-31.
-
(1986)
Dig Dis Sci.
, vol.31
, Issue.10
, pp. 1025-1031
-
-
Mir Madjlessi, S.H.1
Farmer, R.G.2
Weick, J.K.3
-
62
-
-
0033119199
-
Increased risk of cancer in ulcerative colitis: A population-based cohort study
-
Karlen P, Lofberg R, Brostrom O, Leijonmarck CE, Hellers G, Persson PG. Increased risk of cancer in ulcerative colitis: a population-based cohort study. Am J Gastroenterol. 1999;94(4):1047-52.
-
(1999)
Am J Gastroenterol.
, vol.94
, Issue.4
, pp. 1047-1052
-
-
Karlen, P.1
Lofberg, R.2
Brostrom, O.3
Leijonmarck, C.E.4
Hellers, G.5
Persson, P.G.6
-
63
-
-
0035865012
-
Cancer risk in patients with inflammatory bowel disease: A populationbased study
-
Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a populationbased study. Cancer. 2001;91(4):854-62.
-
(2001)
Cancer.
, vol.91
, Issue.4
, pp. 854-862
-
-
Bernstein, C.N.1
Blanchard, J.F.2
Kliewer, E.3
Wajda, A.4
-
64
-
-
17644386242
-
Risk of haematopoietic cancer in patients with inflammatory bowel disease
-
Askling J, Brandt L, Lapidus A, Karlen P, Bjorkholm M, Lofberg R, et al. Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut. 2005;54 (5):617-22.
-
(2005)
Gut.
, vol.54
, Issue.5
, pp. 617-622
-
-
Askling, J.1
Brandt, L.2
Lapidus, A.3
Karlen, P.4
Bjorkholm, M.5
Lofberg, R.6
-
65
-
-
0032754121
-
Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine
-
Korelitz BI, Mirsky FJ, Fleisher MR, Warman JI, Wisch N, Gleim GW. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine. Am J Gastroenterol. 1999;94(11): 3248-53.
-
(1999)
Am J Gastroenterol.
, vol.94
, Issue.11
, pp. 3248-3253
-
-
Korelitz, B.I.1
Mirsky, F.J.2
Fleisher, M.R.3
Warman, J.I.4
Wisch, N.5
Gleim, G.W.6
-
66
-
-
33845482745
-
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
-
Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, et al. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Health Technol Assess. 2006;10(42): iii-iv, xixiii, 1-229.
-
(2006)
Health Technol Assess.
, vol.10
, Issue.42
-
-
Chen, Y.F.1
Jobanputra, P.2
Barton, P.3
Jowett, S.4
Bryan, S.5
Clark, W.6
-
68
-
-
0022508976
-
Colorectal and extracolonic malignancy in ulcerative colitis
-
Mir-Madjlessi SH, Farmer RG, Easley KA, Beck GJ. Colorectal and extracolonic malignancy in ulcerative colitis. Cancer. 1986;58 (7):1569-74.
-
(1986)
Cancer.
, vol.58
, Issue.7
, pp. 1569-1574
-
-
Mir-Madjlessi, S.H.1
Farmer, R.G.2
Easley, K.A.3
Beck, G.J.4
-
69
-
-
17944382692
-
Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study
-
Viscido A, Bagnardi V, Sturniolo GC, Annese V, Frieri G, D'Arienzo A, et al. Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study. Dig Liver Dis. 2001;33(8):686-92.
-
(2001)
Dig Liver Dis.
, vol.33
, Issue.8
, pp. 686-692
-
-
Viscido, A.1
Bagnardi, V.2
Sturniolo, G.C.3
Annese, V.4
Frieri, G.5
D'Arienzo, A.6
-
70
-
-
0031946235
-
General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: The Florence Study
-
Palli D, Trallori G, Saieva C, Tarantino O, Edili E, D'Albasio G, et al. General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence Study. Gut. 1998;42(2): 175-9.
-
(1998)
Gut.
, vol.42
, Issue.2
, pp. 175-179
-
-
Palli, D.1
Trallori, G.2
Saieva, C.3
Tarantino, O.4
Edili, E.5
D'Albasio, G.6
-
71
-
-
1342331541
-
Intestinal and extra-intestinal cancer in Crohn's disease: Follow-up of a population-based cohort in Copenhagen County, Denmark
-
Jess T, Winther KV, Munkholm P, Langholz E, Binder V. Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment Pharmacol Ther. 2004;19(3):287-93.
-
(2004)
Aliment Pharmacol Ther.
, vol.19
, Issue.3
, pp. 287-293
-
-
Jess, T.1
Winther, K.V.2
Munkholm, P.3
Langholz, E.4
Binder, V.5
-
72
-
-
4344640131
-
Clinical management of multiple sclerosis: The treatment paradigm and issues of patient management
-
Stuart WH. Clinical management of multiple sclerosis: the treatment paradigm and issues of patient management. J Manag Care Pharm. 2004;10(3 Suppl B):S19-25.
-
(2004)
J Manag Care Pharm.
, vol.10
, Issue.3 SUPPL. B
-
-
Stuart, W.H.1
-
73
-
-
84993682619
-
Escalating immunotherapy of multiple sclerosis
-
Rieckmann P, Traboulsee A, Devonshire V, Oger J. Escalating immunotherapy of multiple sclerosis. Ther Adv Neurol Disord. 2008;1(3):181-92.
-
(2008)
Ther Adv Neurol Disord.
, vol.1
, Issue.3
, pp. 181-192
-
-
Rieckmann, P.1
Traboulsee, A.2
Devonshire, V.3
Oger, J.4
-
74
-
-
0345305703
-
The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
-
Goodin DS, Arnason BG, Coyle PK, Frohman EM, Paty DW. The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2003;61(10):1332-8.
-
(2003)
Neurology.
, vol.61
, Issue.10
, pp. 1332-1338
-
-
Goodin, D.S.1
Arnason, B.G.2
Coyle, P.K.3
Frohman, E.M.4
Paty, D.W.5
-
75
-
-
79953199080
-
Risk of acute promyelocytic leukemia in multiple sclerosis: Coding variants of DNA repair genes
-
Hasan SK, Buttari F, Ottone T, Voso MT, Hohaus S, Marasco E, et al. Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes. Neurology. 76(12):1059-65.
-
Neurology
, vol.76
, Issue.12
, pp. 1059-1065
-
-
Hasan, S.K.1
Buttari, F.2
Ottone, T.3
Voso, M.T.4
Hohaus, S.5
Marasco, E.6
-
76
-
-
54049153246
-
Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis
-
Hasan SK, Mays AN, Ottone T, Ledda A, La Nasa G, Cattaneo C, et al. Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis. Blood. 2008;112(8):3383-90.
-
(2008)
Blood.
, vol.112
, Issue.8
, pp. 3383-3390
-
-
Hasan, S.K.1
Mays, A.N.2
Ottone, T.3
Ledda, A.4
la Nasa, G.5
Cattaneo, C.6
-
77
-
-
0017140129
-
Acute myeloblastic leukemia after immunodepressive therapy for primary nonmalignant disease
-
Tchernia G, Mielot F, Subtil E, Parmentier C. Acute myeloblastic leukemia after immunodepressive therapy for primary nonmalignant disease. Nouv Rev Fr Hematol Blood Cells. 1976;17(1-2):67-80.
-
(1976)
Nouv Rev Fr Hematol Blood Cells.
, vol.17
, Issue.1-2
, pp. 67-80
-
-
Tchernia, G.1
Mielot, F.2
Subtil, E.3
Parmentier, C.4
-
78
-
-
0021904187
-
Acute leukemia secondary to the treatment of multiple sclerosis with chlorambucil
-
Aymard JP, Witz F, Conroy T, Lederlin P, Humbert JC, Barroche G, et al. [Acute leukemia secondary to the treatment of multiple sclerosis with chlorambucil]. Rev Neurol (Paris). 1985;141(2):152-4.
-
(1985)
Rev Neurol (Paris).
, vol.141
, Issue.2
, pp. 152-154
-
-
Aymard, J.P.1
Witz, F.2
Conroy, T.3
Lederlin, P.4
Humbert, J.C.5
Barroche, G.6
-
79
-
-
33749545516
-
Rapid progression of Myelodysplastic syndrome to acute myeloid leukemia on sequential azathioprine, IFN-beta and copolymer-1 in a patient with multiple sclerosis
-
Then Bergh F, Niklas A, Strauss A, von Ahsen N, Niederwieser D, Schwarz J, et al. Rapid progression of Myelodysplastic syndrome to acute myeloid leukemia on sequential azathioprine, IFN-beta and copolymer-1 in a patient with multiple sclerosis. Acta Haematol. 2006;116(3):207-10.
-
(2006)
Acta Haematol.
, vol.116
, Issue.3
, pp. 207-210
-
-
Then Bergh, F.1
Niklas, A.2
Strauss, A.3
von Ahsen, N.4
Niederwieser, D.5
Schwarz, J.6
-
80
-
-
0031885653
-
Acute promyelocytic leukemia following mitoxantrone as single agent for the treatment of multiple sclerosis
-
Vicari AM, Ciceri F, Folli F, Lanzi R, Colombo B, Comi G, et al. Acute promyelocytic leukemia following mitoxantrone as single agent for the treatment of multiple sclerosis. Leukemia. 1998;12(3):441-2.
-
(1998)
Leukemia.
, vol.12
, Issue.3
, pp. 441-442
-
-
Vicari, A.M.1
Ciceri, F.2
Folli, F.3
Lanzi, R.4
Colombo, B.5
Comi, G.6
-
81
-
-
0037355117
-
Therapy-related acute myelogenous leukaemia (t-AML) in a patient with multiple sclerosis treated with mitoxantrone
-
Heesen C, Bruegmann M, Gbdamosi J, Koch E, Monch A, Buhmann C. Therapy-related acute myelogenous leukaemia (t-AML) in a patient with multiple sclerosis treated with mitoxantrone. Mult Scler. 2003;9(2):213-4.
-
(2003)
Mult Scler.
, vol.9
, Issue.2
, pp. 213-214
-
-
Heesen, C.1
Bruegmann, M.2
Gbdamosi, J.3
Koch, E.4
Monch, A.5
Buhmann, C.6
-
82
-
-
0037868159
-
Therapyrelated acute promyelocytic leukemia
-
Beaumont M, Sanz M, Carli PM, Maloisel F, Thomas X, Detourmignies L, et al. Therapyrelated acute promyelocytic leukemia. J Clin Oncol. 2003;21(11):2123-37.
-
(2003)
J Clin Oncol.
, vol.21
, Issue.11
, pp. 2123-2137
-
-
Beaumont, M.1
Sanz, M.2
Carli, P.M.3
Maloisel, F.4
Thomas, X.5
Detourmignies, L.6
-
83
-
-
4444233652
-
Acute promyelocytic leukemia in a patient with multiple sclerosis following treatment with mitoxantrone
-
Novoselac AV, Reddy S, Sanmugarajah J. Acute promyelocytic leukemia in a patient with multiple sclerosis following treatment with mitoxantrone. Leukemia. 2004;18 (9):1561-2.
-
(2004)
Leukemia.
, vol.18
, Issue.9
, pp. 1561-1562
-
-
Novoselac, A.V.1
Reddy, S.2
Sanmugarajah, J.3
-
84
-
-
0347337764
-
Therapy related acute myeloblastic leukaemia after mitoxantrone treatment in a patient with multiple sclerosis
-
Delisse B, de Seze J, Mackowiak A, N'Kendjuo JB, Verier A, Derepeer O, et al. Therapy related acute myeloblastic leukaemia after mitoxantrone treatment in a patient with multiple sclerosis. Mult Scler. 2004;10(1):92.
-
(2004)
Mult Scler.
, vol.10
, Issue.1
, pp. 92
-
-
Delisse, B.1
de Seze, J.2
Mackowiak, A.3
N'Kendjuo, J.B.4
Verier, A.5
Derepeer, O.6
-
85
-
-
34250667954
-
Clinical follow-up of 304 patients with multiple sclerosis three years after mitoxantrone treatment
-
Debouverie M, Taillandier L, Pittion-Vouyovitch S, Louis S, Vespignani H. Clinical follow-up of 304 patients with multiple sclerosis three years after mitoxantrone treatment. Mult Scler. 2007;13(5):626-31.
-
(2007)
Mult Scler.
, vol.13
, Issue.5
, pp. 626-631
-
-
Debouverie, M.1
Taillandier, L.2
Pittion-Vouyovitch, S.3
Louis, S.4
Vespignani, H.5
-
86
-
-
3042535824
-
Acute myeloid leukaemia induced by mitoxantrone in a multiple sclerosis patient
-
Tanasescu R, Debouverie M, Pittion S, Anxionnat R, Vespignani H. Acute myeloid leukaemia induced by mitoxantrone in a multiple sclerosis patient. J Neurol. 2004; 251(6):762-3.
-
(2004)
J Neurol.
, vol.251
, Issue.6
, pp. 762-763
-
-
Tanasescu, R.1
Debouverie, M.2
Pittion, S.3
Anxionnat, R.4
Vespignani, H.5
-
87
-
-
4344569251
-
Mitoxantrone therapy in multiple sclerosis and acute leukaemia: A case report out of 644 treated patients
-
Voltz R, Starck M, Zingler V, Strupp M, Kolb HJ. Mitoxantrone therapy in multiple sclerosis and acute leukaemia: a case report out of 644 treated patients. Mult Scler. 2004;10(4): 472-4.
-
(2004)
Mult Scler.
, vol.10
, Issue.4
, pp. 472-474
-
-
Voltz, R.1
Starck, M.2
Zingler, V.3
Strupp, M.4
Kolb, H.J.5
-
88
-
-
20644459935
-
Acute myeloid leukaemia induced by mitoxantrone: Case report
-
Arruda WO, Montu MB, de Oliveira Mde S, Ramina R. Acute myeloid leukaemia induced by mitoxantrone: case report. Arq Neuropsiquiatr. 2005;63(2A):327-9.
-
(2005)
Arq Neuropsiquiatr.
, vol.63
, Issue.2 A
, pp. 327-329
-
-
Arruda, W.O.1
Montu, M.B.2
de Oliveira Mde, S.3
Ramina, R.4
-
89
-
-
33749432012
-
Sequential maintenance treatment with glatiramer acetate after mitoxantrone is safe and can limit exposure to immunosuppression in very active, relapsing remitting multiple sclerosis
-
Ramtahal J, Jacob A, Das K, Boggild M. Sequential maintenance treatment with glatiramer acetate after mitoxantrone is safe and can limit exposure to immunosuppression in very active, relapsing remitting multiple sclerosis. J Neurol. 2006;253(9):1160-4.
-
(2006)
J Neurol.
, vol.253
, Issue.9
, pp. 1160-1164
-
-
Ramtahal, J.1
Jacob, A.2
Das, K.3
Boggild, M.4
-
90
-
-
33751254778
-
Two new cases of acute promyelocytic leukemia following mitoxantrone treatment in patients with multiple sclerosis
-
Ledda A, Caocci G, Spinicci G, Cocco E, Mamusa E, La Nasa G. Two new cases of acute promyelocytic leukemia following mitoxantrone treatment in patients with multiple sclerosis. Leukemia. 2006;20(12): 2217-8.
-
(2006)
Leukemia.
, vol.20
, Issue.12
, pp. 2217-2218
-
-
Ledda, A.1
Caocci, G.2
Spinicci, G.3
Cocco, E.4
Mamusa, E.5
la Nasa, G.6
-
91
-
-
33645563825
-
Mitoxantrone as induction therapy in aggressive relapsing remitting multiple sclerosis: A descriptive analysis of 100 consecutive patients
-
Le Page E, Leray E, Taurin G, Coustans M, Chaperon J, Edan G. [Mitoxantrone as induction therapy in aggressive relapsing remitting multiple sclerosis: a descriptive analysis of 100 consecutive patients]. Rev Neurol (Paris). 2006;162(2):185-94.
-
(2006)
Rev Neurol (Paris).
, vol.162
, Issue.2
, pp. 185-194
-
-
le Page, E.1
Leray, E.2
Taurin, G.3
Coustans, M.4
Chaperon, J.5
Edan, G.6
-
92
-
-
43149122122
-
Analysis of incidence, risk factors and prognosis of acute promyelocytic leukaemia related to mitoxantrone therapy in multiple sclerosis
-
Cordioli C, Cattaneo C, Capra R. Analysis of incidence, risk factors and prognosis of acute promyelocytic leukaemia related to mitoxantrone therapy in multiple sclerosis. Neurology 2007;68(Suppl 1):A276.
-
(2007)
Neurology
, vol.68
, Issue.SUPPL. 1
-
-
Cordioli, C.1
Cattaneo, C.2
Capra, R.3
-
93
-
-
57549089217
-
Mitoxantrone-related acute leukemia in two MS patients
-
Pielen A, Goffette S, Van Pesch V, Gille M, Sindic CJ. Mitoxantrone-related acute leukemia in two MS patients. Acta Neurol Belg. 2008;108(3):99-102.
-
(2008)
Acta Neurol Belg.
, vol.108
, Issue.3
, pp. 99-102
-
-
Pielen, A.1
Goffette, S.2
van Pesch, V.3
Gille, M.4
Sindic, C.J.5
-
94
-
-
70450176057
-
Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required
-
Pascual AM, Tellez N, Bosca I, Mallada J, Belenguer A, Abellan I, et al. Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required. Mult Scler. 2009;15(11):1303-10.
-
(2009)
Mult Scler.
, vol.15
, Issue.11
, pp. 1303-1310
-
-
Pascual, A.M.1
Tellez, N.2
Bosca, I.3
Mallada, J.4
Belenguer, A.5
Abellan, I.6
-
95
-
-
77951802924
-
Mitoxantrone-associated leukemia in multiple sclerosis: Case studies
-
Woo DA, Collins RH, Rossman HS, Stüve O, Frohman EM. Mitoxantrone-associated leukemia in multiple sclerosis: case studies. Int J MS Care. 2008;10:41-6.
-
(2008)
Int J MS Care.
, vol.10
, pp. 41-46
-
-
Woo, D.A.1
Collins, R.H.2
Rossman, H.S.3
Stüve, O.4
Frohman, E.M.5
-
96
-
-
77951786239
-
A clinical retrospective report on mitoxantrone treatment in active multiple sclerosis patients
-
Hum S, Lapierre Y. A clinical retrospective report on mitoxantrone treatment in active multiple sclerosis patients. Neurology 2009; 72(Suppl 3):A237.
-
(2009)
Neurology
, vol.72
, Issue.SUPPL. 3
-
-
Hum, S.1
Lapierre, Y.2
-
97
-
-
0036783808
-
A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis
-
Ghalie RG, Mauch E, Edan G, Hartung HP, Gonsette RE, Eisenmann S, et al. A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis. Mult Scler. 2002;8(5):441-5.
-
(2002)
Mult Scler.
, vol.8
, Issue.5
, pp. 441-445
-
-
Ghalie, R.G.1
Mauch, E.2
Edan, G.3
Hartung, H.P.4
Gonsette, R.E.5
Eisenmann, S.6
-
98
-
-
74049139048
-
Post-marketing reports of acute leukemia in mitoxantrone-treated multiple sclerosis patients
-
Rammohan K, Kita M, Lynn D, Dawson D, Bennett R, AL-Sabbagh A, et al. Post-marketing reports of acute leukemia in mitoxantrone-treated multiple sclerosis patients. Multiple Sclerosis. 2008:497.
-
(2008)
Multiple Sclerosis
, vol.497
-
-
Rammohan, K.1
Kita, M.2
Lynn, D.3
Dawson, D.4
Bennett, R.5
Al-Sabbagh, A.6
-
99
-
-
74049140477
-
Mitoxantrone: Benefits and risks in multiple sclerosis patients
-
Martinelli V, Radaelli M, Straffi L, Rodegher M, Comi G. Mitoxantrone: benefits and risks in multiple sclerosis patients. Neurol Sci. 2009;30 (Suppl 2):S167-70.
-
(2009)
Neurol Sci.
, vol.30
, Issue.SUPPL. 2
-
-
Martinelli, V.1
Radaelli, M.2
Straffi, L.3
Rodegher, M.4
Comi, G.5
-
100
-
-
0034034163
-
The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, implying only one rate limiting mutation
-
Vickers M, Jackson G, Taylor P. The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, implying only one rate limiting mutation. Leukemia. 2000;14(4):722-6.
-
(2000)
Leukemia.
, vol.14
, Issue.4
, pp. 722-726
-
-
Vickers, M.1
Jackson, G.2
Taylor, P.3
-
101
-
-
77951828930
-
Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
-
Marriott JJ, Miyasaki JM, Gronseth G, O'Connor PW. Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 74(18):1463-70.
-
Neurology
, vol.74
, Issue.18
, pp. 1463-1470
-
-
Marriott, J.J.1
Miyasaki, J.M.2
Gronseth, G.3
O'Connor, P.W.4
-
102
-
-
63449128972
-
Therapy-related acute leukaemia with Mitoxantrone: What is the risk and can we minimise it
-
Ellis R, Boggild M. Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it? Mult Scler. 2009;15(4):505-8.
-
(2009)
Mult Scler.
, vol.15
, Issue.4
, pp. 505-508
-
-
Ellis, R.1
Boggild, M.2
-
103
-
-
79953888314
-
Presenting features and treatment outcome of acute promyelocytic leukemia arising after multiple sclerosis
-
Ammatuna E, Montesinos P, Hasan SK, Ramadan SM, Esteve J, Hubmann M, et al. Presenting features and treatment outcome of acute promyelocytic leukemia arising after multiple sclerosis. Haematologica. 96(4):621-5.
-
Haematologica
, vol.96
, Issue.4
, pp. 621-625
-
-
Ammatuna, E.1
Montesinos, P.2
Hasan, S.K.3
Ramadan, S.M.4
Esteve, J.5
Hubmann, M.6
-
104
-
-
0037105375
-
Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: The GIMEMA experience
-
Pulsoni A, Pagano L, Lo Coco F, Avvisati G, Mele L, Di Bona E, et al. Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience. Blood. 2002;100 (6):1972-6.
-
(2002)
Blood.
, vol.100
, Issue.6
, pp. 1972-1976
-
-
Pulsoni, A.1
Pagano, L.2
Lo Coco, F.3
Avvisati, G.4
Mele, L.5
Di Bona, E.6
-
105
-
-
38149138096
-
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I
-
Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58(1): 15-25.
-
(2008)
Arthritis Rheum.
, vol.58
, Issue.1
, pp. 15-25
-
-
Helmick, C.G.1
Felson, D.T.2
Lawrence, R.C.3
Gabriel, S.4
Hirsch, R.5
Kwoh, C.K.6
-
106
-
-
44849116038
-
Clinical trials in systemic lupus erythematosus (SLE): Lessons from the past as we proceed to the future--the EULAR recommendations for the management of SLE and the use of endpoints in clinical trials
-
Bertsias G, Gordon C, Boumpas DT. Clinical trials in systemic lupus erythematosus (SLE): lessons from the past as we proceed to the future--the EULAR recommendations for the management of SLE and the use of endpoints in clinical trials. Lupus. 2008;17(5): 437-42.
-
(2008)
Lupus.
, vol.17
, Issue.5
, pp. 437-442
-
-
Bertsias, G.1
Gordon, C.2
Boumpas, D.T.3
-
107
-
-
0014127904
-
Systemic lupus erythematosus and acute myeloblastic leukemia. Report of their coexistence and a survey of possible associating features
-
Deaton JG, Levin WC. Systemic lupus erythematosus and acute myeloblastic leukemia. Report of their coexistence and a survey of possible associating features. Arch Intern Med. 1967;120(3):345-8.
-
(1967)
Arch Intern Med.
, vol.120
, Issue.3
, pp. 345-348
-
-
Deaton, J.G.1
Levin, W.C.2
-
108
-
-
0016284086
-
Multiple myeloma terminating in acute leukemia. Report of 12 cases and review of the literature
-
Rosner F, Grunwald H. Multiple myeloma terminating in acute leukemia. Report of 12 cases and review of the literature. Am J Med. 1974;57(6):927-39.
-
(1974)
Am J Med.
, vol.57
, Issue.6
, pp. 927-939
-
-
Rosner, F.1
Grunwald, H.2
-
109
-
-
0018900976
-
Azathioprine and subacute myelomonocytic leukemia
-
Vismans JJ, Briet E, Meijer K, den Ottolander GJ. Azathioprine and subacute myelomonocytic leukemia. Acta Med Scand. 1980;207 (4):315-9.
-
(1980)
Acta Med Scand.
, vol.207
, Issue.4
, pp. 315-319
-
-
Vismans, J.J.1
Briet, E.2
Meijer, K.3
den Ottolander, G.J.4
-
110
-
-
0019507259
-
A case of systemic lupus erythematosus with sideroblastic anaemia terminating in erythroleukaemia
-
Ng HS, Ng HW, Sinniah R, Feng PH. A case of systemic lupus erythematosus with sideroblastic anaemia terminating in erythroleukaemia. Ann Rheum Dis. 1981;40(4): 422-6.
-
(1981)
Ann Rheum Dis.
, vol.40
, Issue.4
, pp. 422-426
-
-
Ng, H.S.1
Ng, H.W.2
Sinniah, R.3
Feng, P.H.4
-
111
-
-
0020429744
-
Preleukemic syndrome simulating SLE. A case report
-
Saxne T, Turesson I, Wollheim FA. Preleukemic syndrome simulating SLE. A case report. Acta Med Scand. 1982;212(6): 421-4.
-
(1982)
Acta Med Scand.
, vol.212
, Issue.6
, pp. 421-424
-
-
Saxne, T.1
Turesson, I.2
Wollheim, F.A.3
-
112
-
-
0021396150
-
Acute myeloid leukemia with preceding systemic lupus erythematosus and autoimmune hemolytic anemia
-
Tsunematsu Y, Koide R, Sasaki M, Takahashi H. Acute myeloid leukemia with preceding systemic lupus erythematosus and autoimmune hemolytic anemia. Jpn J Clin Oncol. 1984;14(1):107-13.
-
(1984)
Jpn J Clin Oncol.
, vol.14
, Issue.1
, pp. 107-113
-
-
Tsunematsu, Y.1
Koide, R.2
Sasaki, M.3
Takahashi, H.4
-
113
-
-
0022091116
-
Acute granulocytic leukemia following systemic lupus erythematosus
-
Paolozzi FP, Goldberg J. Acute granulocytic leukemia following systemic lupus erythematosus. Am J Med Sci. 1985;290(1):32-5.
-
(1985)
Am J Med Sci.
, vol.290
, Issue.1
, pp. 32-35
-
-
Paolozzi, F.P.1
Goldberg, J.2
-
114
-
-
0024245628
-
Acute nonlymphocytic leukemia following short-term, intermittent, intravenous cyclophosphamide treatment of lupus nephritis
-
Gibbons RB, Westerman E. Acute nonlymphocytic leukemia following short-term, intermittent, intravenous cyclophosphamide treatment of lupus nephritis. Arthritis Rheum. 1988;31(12):1552-4.
-
(1988)
Arthritis Rheum.
, vol.31
, Issue.12
, pp. 1552-1554
-
-
Gibbons, R.B.1
Westerman, E.2
-
115
-
-
0025580669
-
Acute promyelocytic leukemia developed in the course of systemic lupus erythematosus: A case report
-
Taguchi F, Miyoshi T, Nakajima N, Nishimura J, Nawata H. [Acute promyelocytic leukemia developed in the course of systemic lupus erythematosus: a case report]. Rinsho Ketsueki. 1990;31(12):1965-6.
-
(1990)
Rinsho Ketsueki.
, vol.31
, Issue.12
, pp. 1965-1966
-
-
Taguchi, F.1
Miyoshi, T.2
Nakajima, N.3
Nishimura, J.4
Nawata, H.5
-
116
-
-
0026473159
-
Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents
-
Vasquez S, Kavanaugh AF, Schneider NR, Wacholtz MC, Lipsky PE. Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents. J Rheumatol. 1992;19 (10):1625-7.
-
(1992)
J Rheumatol.
, vol.19
, Issue.10
, pp. 1625-1627
-
-
Vasquez, S.1
Kavanaugh, A.F.2
Schneider, N.R.3
Wacholtz, M.C.4
Lipsky, P.E.5
-
117
-
-
0030844711
-
Acute megakaryoblastic leukaemia in a patient with systemic lupus erythematosus
-
Colovic M, Jankovic G, Lazarevic V, Novak A. Acute megakaryoblastic leukaemia in a patient with systemic lupus erythematosus. Med Oncol. 1997;14(1):31-4.
-
(1997)
Med Oncol.
, vol.14
, Issue.1
, pp. 31-34
-
-
Colovic, M.1
Jankovic, G.2
Lazarevic, V.3
Novak, A.4
-
118
-
-
0030979803
-
Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: Regression of both diseases after autologous bone marrow transplantation
-
Meloni G, Capria S, Vignetti M, Mandelli F, Modena V. Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation. Blood. 1997;89(12):4659.
-
(1997)
Blood.
, vol.89
, Issue.12
, pp. 4659
-
-
Meloni, G.1
Capria, S.2
Vignetti, M.3
Mandelli, F.4
Modena, V.5
-
119
-
-
37349118282
-
Erythroleukaemia complicating ANA-negative systemic lupus erythematosus
-
Eilertsen GO, Nossent JC. Erythroleukaemia complicating ANA-negative systemic lupus erythematosus. Scand J Rheumatol. 2007; 36(6):478-80.
-
(2007)
Scand J Rheumatol.
, vol.36
, Issue.6
, pp. 478-480
-
-
Eilertsen, G.O.1
Nossent, J.C.2
-
120
-
-
70350783976
-
Myeloid leukaemia in systemic lupus erythematosus--a nested case-control study based on Swedish registers
-
Lofstrom B, Backlin C, Sundstrom C, Hellstrom-Lindberg E, Ekbom A, Lundberg IE. Myeloid leukaemia in systemic lupus erythematosus--a nested case-control study based on Swedish registers. Rheumatology (Oxford). 2009;48(10):1222-6.
-
(2009)
Rheumatology (Oxford).
, vol.48
, Issue.10
, pp. 1222-1226
-
-
Lofstrom, B.1
Backlin, C.2
Sundstrom, C.3
Hellstrom-Lindberg, E.4
Ekbom, A.5
Lundberg, I.E.6
-
121
-
-
19544378505
-
Exploring the links between systemic lupus erythematosus and cancer
-
Bernatsky S, Ramsey-Goldman R, Clarke A. Exploring the links between systemic lupus erythematosus and cancer. Rheum Dis Clin North Am. 2005;31(2):387-402, viii-ix.
-
(2005)
Rheum Dis Clin North Am.
, vol.31
, Issue.2
-
-
Bernatsky, S.1
Ramsey-Goldman, R.2
Clarke, A.3
-
122
-
-
34948884016
-
Occurrence of malignancies in Hungarian patients with systemic lupus erythematosus: Results from a single center
-
Tarr T, Gyorfy B, Szekanecz E, Bhattoa HP, Zeher M, Szegedi G, et al. Occurrence of malignancies in Hungarian patients with systemic lupus erythematosus: results from a single center. Ann NY Acad Sci. 2007; 1108:76-82.
-
(2007)
Ann NY Acad Sci.
, vol.1108
, pp. 76-82
-
-
Tarr, T.1
Gyorfy, B.2
Szekanecz, E.3
Bhattoa, H.P.4
Zeher, M.5
Szegedi, G.6
-
123
-
-
0036247498
-
Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades
-
Moss KE, Ioannou Y, Sultan SM, Haq I, Isenberg DA. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis. 2002;61(5):409-13.
-
(2002)
Ann Rheum Dis.
, vol.61
, Issue.5
, pp. 409-413
-
-
Moss, K.E.1
Ioannou, Y.2
Sultan, S.M.3
Haq, I.4
Isenberg, D.A.5
-
124
-
-
33845976381
-
Mortality related to cerebrovascular disease in systemic lupus erythematosus
-
Bernatsky S, Clarke A, Gladman DD, Urowitz M, Fortin PR, Barr SG, et al. Mortality related to cerebrovascular disease in systemic lupus erythematosus. Lupus. 2006;15(12):835-9.
-
(2006)
Lupus.
, vol.15
, Issue.12
, pp. 835-839
-
-
Bernatsky, S.1
Clarke, A.2
Gladman, D.D.3
Urowitz, M.4
Fortin, P.R.5
Barr, S.G.6
-
125
-
-
33846176558
-
Scleroderma and chronic myeloid leukemia: A sheer coincidence, a consequence of long lasting D-penicillamine therapy or a plausible relationship of both diseases
-
Kasifoglu T, Korkmaz C, Yasar S, Gulbas Z. Scleroderma and chronic myeloid leukemia: a sheer coincidence, a consequence of long lasting D-penicillamine therapy or a plausible relationship of both diseases? Rheumatol Int. 2006;27(2):175-7.
-
(2006)
Rheumatol Int.
, vol.27
, Issue.2
, pp. 175-177
-
-
Kasifoglu, T.1
Korkmaz, C.2
Yasar, S.3
Gulbas, Z.4
-
126
-
-
33745059043
-
Rheumatic diseases and chronic myelogenous leukemia, presentation of four cases and review of the literature
-
Senel S, Kaya E, Aydogdu I, Erkurt MA, Kuku I. Rheumatic diseases and chronic myelogenous leukemia, presentation of four cases and review of the literature. Rheumatol Int. 2006;26(9):857-61.
-
(2006)
Rheumatol Int.
, vol.26
, Issue.9
, pp. 857-861
-
-
Senel, S.1
Kaya, E.2
Aydogdu, I.3
Erkurt, M.A.4
Kuku, I.5
-
127
-
-
0028504360
-
Concordant improvement of progressive systemic sclerosis and chronic myelogenous leukemia with interferon-alpha treatment
-
Watanabe S, Sugihara T, Takahashi M, Ata K, Kanzaki A, Yamada O, et al. [Concordant improvement of progressive systemic sclerosis and chronic myelogenous leukemia with interferon-alpha treatment]. Rinsho Ketsueki. 1994;35(9):895-7.
-
(1994)
Rinsho Ketsueki.
, vol.35
, Issue.9
, pp. 895-897
-
-
Watanabe, S.1
Sugihara, T.2
Takahashi, M.3
Ata, K.4
Kanzaki, A.5
Yamada, O.6
-
128
-
-
0025605931
-
Systemic sclerosis and chronic lymphocytic leukaemia
-
Sidi Y, Fadilah R, Pinkhas J, Prokocimer M. Systemic sclerosis and chronic lymphocytic leukaemia. Postgrad Med J. 1990;66(782): 1071-2.
-
(1990)
Postgrad Med J.
, vol.66
, Issue.782
, pp. 1071-1072
-
-
Sidi, Y.1
Fadilah, R.2
Pinkhas, J.3
Prokocimer, M.4
-
129
-
-
0025859432
-
Chronic lymphoid leukemia in a case of systemic scleroderma
-
Angeli C, Lacour JP, Taillan B, Ortonne JP. [Chronic lymphoid leukemia in a case of systemic scleroderma]. Presse Med. 1991;20 (9):426.
-
(1991)
Presse Med.
, vol.20
, Issue.9
, pp. 426
-
-
Angeli, C.1
Lacour, J.P.2
Taillan, B.3
Ortonne, J.P.4
-
130
-
-
4544319441
-
Large granular lymphocyte leukaemia associated with systemic sclerosis
-
Charlanne H, Lambert M, Hachulla E, Launay D, Queyrel V, Hatron PY, et al. Large granular lymphocyte leukaemia associated with systemic sclerosis. Rheumatology (Oxford). 2004;43(9):1197-8.
-
(2004)
Rheumatology (Oxford).
, vol.43
, Issue.9
, pp. 1197-1198
-
-
Charlanne, H.1
Lambert, M.2
Hachulla, E.3
Launay, D.4
Queyrel, V.5
Hatron, P.Y.6
-
131
-
-
0029045209
-
Scleroderma, polymyositis, and hairy cell leukemia
-
Blanche P, Bachmeyer C, Mikdame M, Dreyfus F, Sicard D. Scleroderma, polymyositis, and hairy cell leukemia. J Rheumatol. 1995;22(7):1384-5.
-
(1995)
J Rheumatol.
, vol.22
, Issue.7
, pp. 1384-1385
-
-
Blanche, P.1
Bachmeyer, C.2
Mikdame, M.3
Dreyfus, F.4
Sicard, D.5
-
132
-
-
0028236707
-
Scleroderma and hairy-cell leukemia
-
Cavallero GB, Bonferroni M, Gallamini A, Grasso M, Carbone A. Scleroderma and hairy-cell leukemia. Eur J Haematol. 1994;52 (3):189-90.
-
(1994)
Eur J Haematol.
, vol.52
, Issue.3
, pp. 189-190
-
-
Cavallero, G.B.1
Bonferroni, M.2
Gallamini, A.3
Grasso, M.4
Carbone, A.5
-
133
-
-
0027596435
-
Systemic scleroderma and hairy cell leukemia. A new case
-
Constans J, Cadenne M, Schaeverbeke T, Leman C, Aupy M, Broustet A, et al. [Systemic scleroderma and hairy cell leukemia. A new case]. Rev Rhum Ed Fr. 1993;60(5):371-2.
-
(1993)
Rev Rhum Ed Fr.
, vol.60
, Issue.5
, pp. 371-372
-
-
Constans, J.1
Cadenne, M.2
Schaeverbeke, T.3
Leman, C.4
Aupy, M.5
Broustet, A.6
-
134
-
-
0024588821
-
Atypical scleroderma associated with multiple myeloma
-
Nakanishi H, Takehara K, Soma Y, Ishibashi Y. Atypical scleroderma associated with multiple myeloma. Dermatologica. 1989; 178(3):176-8.
-
(1989)
Dermatologica.
, vol.178
, Issue.3
, pp. 176-178
-
-
Nakanishi, H.1
Takehara, K.2
Soma, Y.3
Ishibashi, Y.4
-
135
-
-
33645009877
-
Solitary extramedullary plasmacytoma and granulomatous sialadenitis of the parotid gland preceding a B-cell non-Hodgkin's lymphoma
-
Gouveris H, Hansen T, Franke K. Solitary extramedullary plasmacytoma and granulomatous sialadenitis of the parotid gland preceding a B-cell non-Hodgkin's lymphoma. Mund Kiefer Gesichtschir. 2006;10(2):122-5.
-
(2006)
Mund Kiefer Gesichtschir.
, vol.10
, Issue.2
, pp. 122-125
-
-
Gouveris, H.1
Hansen, T.2
Franke, K.3
-
136
-
-
0026009468
-
Non-Hodgkin's lymphoma associated with scleroderma
-
Pulik M, Teillet-Thiebaud F, Mahe A, Teillet F. [Non-Hodgkin's lymphoma associated with scleroderma]. Presse Med. 1991;20(31): 1513-4.
-
(1991)
Presse Med.
, vol.20
, Issue.31
, pp. 1513-1514
-
-
Pulik, M.1
Teillet-Thiebaud, F.2
Mahe, A.3
Teillet, F.4
-
137
-
-
0036769214
-
Hodgkin's disease and scleroderma
-
Duggal L, Gupta S, Aggarwal PK, Sachar VP, Bhalla S. Hodgkin's disease and scleroderma. J Assoc Physicians India. 2002;50:1186-8.
-
(2002)
J Assoc Physicians India.
, vol.50
, pp. 1186-1188
-
-
Duggal, L.1
Gupta, S.2
Aggarwal, P.K.3
Sachar, V.P.4
Bhalla, S.5
-
138
-
-
48449085252
-
Incidence of lymphoma in systemic sclerosis: A retrospective analysis of 218 Hungarian patients with systemic sclerosis
-
Szekanecz E, Szamosi S, Gergely L, Keszthelyi P, Szekanecz Z, Szucs G. Incidence of lymphoma in systemic sclerosis: a retrospective analysis of 218 Hungarian patients with systemic sclerosis. Clin Rheumatol. 2008;27(9):1163-6.
-
(2008)
Clin Rheumatol.
, vol.27
, Issue.9
, pp. 1163-1166
-
-
Szekanecz, E.1
Szamosi, S.2
Gergely, L.3
Keszthelyi, P.4
Szekanecz, Z.5
Szucs, G.6
-
139
-
-
0017846545
-
Association of systemic scleroderma with lymphocytic leukemia
-
Golovanova OE, Pechorina EG. [Association of systemic scleroderma with lymphocytic leukemia]. Ter Arkh. 1978;50(6):131-4.
-
(1978)
Ter Arkh.
, vol.50
, Issue.6
, pp. 131-134
-
-
Golovanova, O.E.1
Pechorina, E.G.2
-
140
-
-
76549235689
-
Scleroderma associated with malignant estrapenic leukoblastosis ("leukemia"); case report illustrating therapeutic response to orally administered crude "B" fermentation concentrates
-
Barnard RD, Appel A. Scleroderma associated with malignant estrapenic leukoblastosis ("leukemia"); case report illustrating therapeutic response to orally administered crude "B" fermentation concentrates. Urol Cutaneous Rev. 1950;54(6):345-8.
-
(1950)
Urol Cutaneous Rev.
, vol.54
, Issue.6
, pp. 345-348
-
-
Barnard, R.D.1
Appel, A.2
-
141
-
-
0024655082
-
Scleroderma, Gougerot-Sjogren syndrome and myelomonocytic leukemia
-
Dupond JL, Humbert P, Fest T, de Wazieres B. [Scleroderma, Gougerot-Sjogren syndrome and myelomonocytic leukemia]. Rev Rhum Mal Osteoartic. 1989;56(5):425-6.
-
(1989)
Rev Rhum Mal Osteoartic.
, vol.56
, Issue.5
, pp. 425-426
-
-
Dupond, J.L.1
Humbert, P.2
Fest, T.3
de Wazieres, B.4
-
142
-
-
0019961648
-
Acute lymphoblastic leukemia in a patient receiving penicillamine for Wilson's disease
-
Gilman PA, Holtzman NA. Acute lymphoblastic leukemia in a patient receiving penicillamine for Wilson's disease. JAMA. 1982;248(4):467-8.
-
(1982)
JAMA.
, vol.248
, Issue.4
, pp. 467-468
-
-
Gilman, P.A.1
Holtzman, N.A.2
-
143
-
-
0017809875
-
Chronic lymphocytic leukaemia after treatment with penicillamine
-
Clausen JE, Arndal JC, Gram L, Kudahl SB. Chronic lymphocytic leukaemia after treatment with penicillamine. Lancet. 1978;2 (8081):152.
-
(1978)
Lancet.
, vol.2
, Issue.8081
, pp. 152
-
-
Clausen, J.E.1
Arndal, J.C.2
Gram, L.3
Kudahl, S.B.4
-
144
-
-
0034657370
-
Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer
-
Ramenghi U, Bonissoni S, Migliaretti G, DeFranco S, Bottarel F, Gambaruto C, et al. Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer. Blood. 2000;95 (10):3176-82.
-
(2000)
Blood.
, vol.95
, Issue.10
, pp. 3176-3182
-
-
Ramenghi, U.1
Bonissoni, S.2
Migliaretti, G.3
de Franco, S.4
Bottarel, F.5
Gambaruto, C.6
-
145
-
-
79957643482
-
The new era of autoimmune disease research
-
Koike T. The new era of autoimmune disease research. Arthritis Res Ther. 2011; 13(3):113.
-
(2011)
Arthritis Res Ther.
, vol.13
, Issue.3
, pp. 113
-
-
Koike, T.1
-
146
-
-
0036022402
-
Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update
-
Soldani C, Scovassi AI. Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. Apoptosis. 2002;7(4):321-8.
-
(2002)
Apoptosis.
, vol.7
, Issue.4
, pp. 321-328
-
-
Soldani, C.1
Scovassi, A.I.2
-
147
-
-
0034995205
-
Mutations in apoptosis genes: A pathogenetic factor for human disease
-
Mullauer L, Gruber P, Sebinger D, Buch J, Wohlfart S, Chott A. Mutations in apoptosis genes: a pathogenetic factor for human disease. Mutat Res. 2001;488(3):211-31.
-
(2001)
Mutat Res.
, vol.488
, Issue.3
, pp. 211-231
-
-
Mullauer, L.1
Gruber, P.2
Sebinger, D.3
Buch, J.4
Wohlfart, S.5
Chott, A.6
-
148
-
-
38549139638
-
Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome
-
Cerutti E, Campagnoli MF, Ferretti M, Garelli E, Crescenzio N, Rosolen A, et al. Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome. BMC Immunol. 2007;8:28.
-
(2007)
BMC Immunol.
, vol.8
, pp. 28
-
-
Cerutti, E.1
Campagnoli, M.F.2
Ferretti, M.3
Garelli, E.4
Crescenzio, N.5
Rosolen, A.6
-
149
-
-
59649094980
-
A possible role of Fas-ligand-mediated "reverse signaling" in pathogenesis of rheumatoid arthritis and systemic lupus erythematosus
-
Telegina E, Reshetnyak T, Moshnikova A, Proussakova O, Zhukova A, Kuznetsova A, et al. A possible role of Fas-ligand-mediated "reverse signaling" in pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. Immunol Lett. 2009;122(1):12-7.
-
(2009)
Immunol Lett.
, vol.122
, Issue.1
, pp. 12-17
-
-
Telegina, E.1
Reshetnyak, T.2
Moshnikova, A.3
Proussakova, O.4
Zhukova, A.5
Kuznetsova, A.6
-
150
-
-
34548642127
-
Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: From bench to bedside
-
Martelli AM, Tazzari PL, Evangelisti C, Chiarini F, Blalock WL, Billi AM, et al. Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside. Curr Med Chem. 2007;14(19):2009-23.
-
(2007)
Curr Med Chem.
, vol.14
, Issue.19
, pp. 2009-2023
-
-
Martelli, A.M.1
Tazzari, P.L.2
Evangelisti, C.3
Chiarini, F.4
Blalock, W.L.5
Billi, A.M.6
-
151
-
-
79960235543
-
Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy
-
Steelman LS, Franklin RA, Abrams SL, Chappell W, Kempf CR, Basecke J, et al. Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. Leukemia. 2011;25(7): 1080-94.
-
(2011)
Leukemia.
, vol.25
, Issue.7
, pp. 1080-1094
-
-
Steelman, L.S.1
Franklin, R.A.2
Abrams, S.L.3
Chappell, W.4
Kempf, C.R.5
Basecke, J.6
-
152
-
-
11244331548
-
PI3K/AKT signaling and systemic autoimmunity
-
Patel RK, Mohan C. PI3K/AKT signaling and systemic autoimmunity. Immunol Res. 2005;31(1):47-55.
-
(2005)
Immunol Res.
, vol.31
, Issue.1
, pp. 47-55
-
-
Patel, R.K.1
Mohan, C.2
-
153
-
-
77953116018
-
Phosphoinositide 3-kinase gamma (PI3Kgamma) inhibitors for the treatment of inflammation and autoimmune disease
-
Venable JD, Ameriks MK, Blevitt JM, Thurmond RL, Fung-Leung WP. Phosphoinositide 3-kinase gamma (PI3Kgamma) inhibitors for the treatment of inflammation and autoimmune disease. Recent Pat Inflamm Allergy Drug Discov. 4(1):1-15.
-
Recent Pat Inflamm Allergy Drug Discov
, vol.4
, Issue.1
, pp. 1-15
-
-
Venable, J.D.1
Ameriks, M.K.2
Blevitt, J.M.3
Thurmond, R.L.4
Fung-Leung, W.P.5
-
154
-
-
80052043181
-
Inhibition of inflammatory mediators and related signaling pathways by macrophage-stimulating protein in rheumatoid arthritis synovial fibroblasts
-
Tong XM, Wang JC, Shen Y, Xie JJ, Zhang JY, Jin J. Inhibition of inflammatory mediators and related signaling pathways by macrophage-stimulating protein in rheumatoid arthritis synovial fibroblasts. Inflamm Res. 2011;60(9):823-9.
-
(2011)
Inflamm Res.
, vol.60
, Issue.9
, pp. 823-829
-
-
Tong, X.M.1
Wang, J.C.2
Shen, Y.3
Xie, J.J.4
Zhang, J.Y.5
Jin, J.6
-
155
-
-
77951902758
-
PI3K/Akt signaling in peripheral T lymphocytes from systemic lupus erythematosus patients
-
Besliu AN, Pistol G, Marica CM, Banica LM, Chitonu C, Ionescu R, et al. PI3K/Akt signaling in peripheral T lymphocytes from systemic lupus erythematosus patients. Roum Arch Microbiol Immunol. 2009;68(2):69-79.
-
(2009)
Roum Arch Microbiol Immunol.
, vol.68
, Issue.2
, pp. 69-79
-
-
Besliu, A.N.1
Pistol, G.2
Marica, C.M.3
Banica, L.M.4
Chitonu, C.5
Ionescu, R.6
-
156
-
-
67650303113
-
The AKT axis as a therapeutic target in autoimmune diseases
-
Wu T, Mohan C. The AKT axis as a therapeutic target in autoimmune diseases. Endocr Metab Immune Disord Drug Targets. 2009;9(2):145-50.
-
(2009)
Endocr Metab Immune Disord Drug Targets.
, vol.9
, Issue.2
, pp. 145-150
-
-
Wu, T.1
Mohan, C.2
-
157
-
-
83755166163
-
Physiological roles of mitogenactivated-protein-kinase-activated p38-regulated/ activated protein kinase
-
Kostenko S, Dumitriu G, Laegreid KJ, Moens U. Physiological roles of mitogenactivated-protein-kinase-activated p38-regulated/ activated protein kinase. World J Biol Chem. 2011;2(5):73-89.
-
(2011)
World J Biol Chem.
, vol.2
, Issue.5
, pp. 73-89
-
-
Kostenko, S.1
Dumitriu, G.2
Laegreid, K.J.3
Moens, U.4
-
158
-
-
69449088578
-
MAPK signaling pathways in the regulation of hematopoiesis
-
Geest CR, Coffer PJ. MAPK signaling pathways in the regulation of hematopoiesis. J Leukoc Biol. 2009;86(2):237-50.
-
(2009)
J Leukoc Biol.
, vol.86
, Issue.2
, pp. 237-250
-
-
Geest, C.R.1
Coffer, P.J.2
-
159
-
-
68249131563
-
Molecular signaling blockade as a new approach to inhibit leukocyte-endothelial interactions for inflammatory bowel disease treatment
-
Scaldaferri F, Correale C, Gasbarrini A, Danese S. Molecular signaling blockade as a new approach to inhibit leukocyte-endothelial interactions for inflammatory bowel disease treatment. Cell Adh Migr. 2009;3(3): 296-9.
-
(2009)
Cell Adh Migr.
, vol.3
, Issue.3
, pp. 296-299
-
-
Scaldaferri, F.1
Correale, C.2
Gasbarrini, A.3
Danese, S.4
-
160
-
-
77953177649
-
Cancer immunoediting from immunosurveillance to tumor escape in microvillus-formed niche: A study of syngeneic orthotopic rat bladder cancer model in comparison with human bladder cancer
-
Arum CJ, Anderssen E, Viset T, Kodama Y, Lundgren S, Chen D, et al. Cancer immunoediting from immunosurveillance to tumor escape in microvillus-formed niche: a study of syngeneic orthotopic rat bladder cancer model in comparison with human bladder cancer. Neoplasia. 2010;12(6):434-42.
-
(2010)
Neoplasia.
, vol.12
, Issue.6
, pp. 434-442
-
-
Arum, C.J.1
Anderssen, E.2
Viset, T.3
Kodama, Y.4
Lundgren, S.5
Chen, D.6
-
161
-
-
34047220868
-
Cancer immunoediting from immune surveillance to immune escape
-
Kim R, Emi M, Tanabe K. Cancer immunoediting from immune surveillance to immune escape. Immunology. 2007;121 (1):1-14.
-
(2007)
Immunology.
, vol.121
, Issue.1
, pp. 1-14
-
-
Kim, R.1
Emi, M.2
Tanabe, K.3
-
162
-
-
47849098044
-
Inflammation: Gearing the journey to cancer
-
Kundu JK, Surh YJ. Inflammation: gearing the journey to cancer. Mutat Res. 2008;659 (1-2):15-30.
-
(2008)
Mutat Res.
, vol.659
, Issue.1-2
, pp. 15-30
-
-
Kundu, J.K.1
Surh, Y.J.2
-
163
-
-
68449097467
-
Towards understanding the role of cancer-associated inflammation in chemoresistance
-
de Visser KE, Jonkers J. Towards understanding the role of cancer-associated inflammation in chemoresistance. Curr Pharm Des. 2009;15(16):1844-53.
-
(2009)
Curr Pharm Des.
, vol.15
, Issue.16
, pp. 1844-1853
-
-
de Visser, K.E.1
Jonkers, J.2
-
164
-
-
33750467991
-
Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models
-
Gerondakis S, Grumont R, Gugasyan R, Wong L, Isomura I, Ho W, et al. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene. 2006;25(51):6781-99.
-
(2006)
Oncogene.
, vol.25
, Issue.51
, pp. 6781-6799
-
-
Gerondakis, S.1
Grumont, R.2
Gugasyan, R.3
Wong, L.4
Isomura, I.5
Ho, W.6
-
165
-
-
0037180757
-
Inflammation and cancer
-
Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860-7.
-
(2002)
Nature.
, vol.420
, Issue.6917
, pp. 860-867
-
-
Coussens, L.M.1
Werb, Z.2
-
166
-
-
67849128689
-
Stronger inflammatory/cytotoxic T-cell response in women identified by microarray analysis
-
Hewagama A, Patel D, Yarlagadda S, Strickland FM, Richardson BC. Stronger inflammatory/cytotoxic T-cell response in women identified by microarray analysis. Genes Immun. 2009;10(5):509-16.
-
(2009)
Genes Immun.
, vol.10
, Issue.5
, pp. 509-516
-
-
Hewagama, A.1
Patel, D.2
Yarlagadda, S.3
Strickland, F.M.4
Richardson, B.C.5
-
167
-
-
0026596863
-
The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated
-
Young NS. The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated. Blood. 1992;79(6):1385-92.
-
(1992)
Blood.
, vol.79
, Issue.6
, pp. 1385-1392
-
-
Young, N.S.1
-
168
-
-
0015071763
-
Spontaneous reticulum cell sarcomas developing in C3H-HeJ mice on prolonged immunosuppressive therapy
-
Hattan D, Cerilli GJ. Spontaneous reticulum cell sarcomas developing in C3H-HeJ mice on prolonged immunosuppressive therapy. Transplantation. 1971;11(6):580-1.
-
(1971)
Transplantation.
, vol.11
, Issue.6
, pp. 580-581
-
-
Hattan, D.1
Cerilli, G.J.2
-
169
-
-
0016589060
-
Accelerated induction of skin cancers by ultraviolet radiation in hairless mice treated with immunosuppressive agents
-
Koranda FC, Loeffler RT, Koranda DM, Penn I. Accelerated induction of skin cancers by ultraviolet radiation in hairless mice treated with immunosuppressive agents. Surg Forum. 1975;26:145-6.
-
(1975)
Surg Forum.
, vol.26
, pp. 145-146
-
-
Koranda, F.C.1
Loeffler, R.T.2
Koranda, D.M.3
Penn, I.4
-
170
-
-
0015036176
-
Immunosuppression, virus and oncogenesis in mice
-
Nehlsen SL. Immunosuppression, virus and oncogenesis in mice. Transplant Proc. 1971;3 (1):811-3.
-
(1971)
Transplant Proc.
, vol.3
, Issue.1
, pp. 811-813
-
-
Nehlsen, S.L.1
-
171
-
-
78649355858
-
Azathioprine-induced carcinogenesis in mice according to Msh2 genotype
-
Chalastanis A, Penard-Lacronique V, Svrcek M, Defaweux V, Antoine N, Buhard O, et al. Azathioprine-induced carcinogenesis in mice according to Msh2 genotype. J Natl Cancer Inst. 2010;102(22):1731-40.
-
(2010)
J Natl Cancer Inst.
, vol.102
, Issue.22
, pp. 1731-1740
-
-
Chalastanis, A.1
Penard-Lacronique, V.2
Svrcek, M.3
Defaweux, V.4
Antoine, N.5
Buhard, O.6
-
172
-
-
77953522671
-
Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: Association of DNA breaks with specific DNA motifs at PML and RARA loci
-
Hasan SK, Ottone T, Schlenk RF, Xiao Y, Wiemels JL, Mitra ME, et al. Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci. Genes Chromosomes Cancer. 2010;49(8):726-32.
-
(2010)
Genes Chromosomes Cancer.
, vol.49
, Issue.8
, pp. 726-732
-
-
Hasan, S.K.1
Ottone, T.2
Schlenk, R.F.3
Xiao, Y.4
Wiemels, J.L.5
Mitra, M.E.6
-
173
-
-
36348967181
-
Therapy-related leukemia and myelodysplasia: Susceptibility and incidence
-
Leone G, Pagano L, Ben-Yehuda D, Voso MT. Therapy-related leukemia and myelodysplasia: susceptibility and incidence. Haematologica. 2007;92(10):1389-98.
-
(2007)
Haematologica.
, vol.92
, Issue.10
, pp. 1389-1398
-
-
Leone, G.1
Pagano, L.2
Ben-Yehuda, D.3
Voso, M.T.4
-
174
-
-
77958487251
-
Occupational Exposure to Ethylene Oxide and Risk of Lymphoma
-
Kiran S, Cocco P, Mannetje A, Satta G, D'Andrea I, Becker N, et al. Occupational Exposure to Ethylene Oxide and Risk of Lymphoma. Epidemiology. 2010;21(6):905-10.
-
(2010)
Epidemiology.
, vol.21
, Issue.6
, pp. 905-910
-
-
Kiran, S.1
Cocco, P.2
Mannetje, A.3
Satta, G.4
D'Andrea, I.5
Becker, N.6
-
175
-
-
0029088161
-
Risk of malignancy in women with systemic lupus erythematosus
-
Sweeney DM, Manzi S, Janosky J, Selvaggi KJ, Ferri W, Medsger TA Jr, et al. Risk of malignancy in women with systemic lupus erythematosus. J Rheumatol. 1995;22(8): 1478-82.
-
(1995)
J Rheumatol.
, vol.22
, Issue.8
, pp. 1478-1482
-
-
Sweeney, D.M.1
Manzi, S.2
Janosky, J.3
Selvaggi, K.J.4
Ferri, W.5
Medsger Jr., T.A.6
-
176
-
-
0027164953
-
The association of malignancy with SLE: An analysis of 150 patients under long-term review
-
Menon S, Snaith ML, Isenberg DA. The association of malignancy with SLE: an analysis of 150 patients under long-term review. Lupus. 1993;2(3):177-81.
-
(1993)
Lupus.
, vol.2
, Issue.3
, pp. 177-181
-
-
Menon, S.1
Snaith, M.L.2
Isenberg, D.A.3
|